It’s the first rapid point-of-care test that detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, which can appear just 12 to 26 days after infection.1,2
It helps healthcare providers to break the infection cycle by screening for acute HIV infection earlier than traditional 3rd generation HIV antibody tests.3, 4, 5
It provides clear results in just 20 minutes, with built-in quality controls to let you know the test is working.
It requires minimal training and no expensive laboratory equipment.
It’s designed for fingerstick testing of whole blood, as well as serum or plasma samples.